BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/19/2016 9:45:00 AM | Browse: 1221 | Download: 2982
 |
Received |
|
2015-11-26 08:56 |
 |
Peer-Review Started |
|
2015-11-26 16:53 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2015-12-30 17:29 |
 |
Revised |
|
2016-02-01 16:32 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2016-02-19 09:24 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2016-03-02 08:11 |
 |
Articles in Press |
|
2016-03-02 08:11 |
 |
Edit the Manuscript by Language Editor |
|
2016-03-08 16:50 |
 |
Typeset the Manuscript |
|
2016-04-01 17:23 |
 |
Publish the Manuscript Online |
|
2016-04-19 09:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dan-Dan Gao, Jia Fu, Bo Qin, Wen-Xiang Huang, Chun Yang and Bei Jia |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Chongqing |
cstc2012jjA10052 |
| Young High-End Medical Reserve Personnel Training Plan Foundation of Chongqing, China |
|
|
| Corresponding Author |
Bei Jia, PhD, Chongqing Key Laboratory of Infectious Diseases and Parasitic Diseases, Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yu Zhong District, Chongqing 400016, China. beijia7410@163.com
|
| Key Words |
Acute-on-chronic liver failure; Recombinant adenovirus; Hyper-interleukin-6; Hepatocyte growth factor; Inflammatory cytokines |
| Core Tip |
The purport of our study was to analyse the protective efficacy of recombinant adenovirus containing hyper-interleukin-6 (Hyper-IL-6, HIL-6) and hepatocyte growth factor (HGF) (Ad-HGF-HIL-6) compared to that of recombinant adenovirus HIL-6 or HGF (Ad-HIL-6 or Ad-HGF) in rats with acute-on-chronic liver failure (ACLF). In summary, our results suggest that Ad-HGF-HIL-6 may confer a more powerful protective effect against ACLF than do Ad-HGF or Ad-HIL-6 in rats and can restrain the secretion of diverse inflammatory cytokines and reduce the apoptosis of hepatocytes. Ad-HGF-HIL-6 is likely to be a feasible protective therapy for serious liver injury.
|
| Publish Date |
2016-04-19 09:42 |
| Citation |
Gao DD, Fu J, Qin B, Huang WX, Yang C, Jia B. Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats. World J Gastroenterol 2016; 22(16): 4136-4148 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i16/4136.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i16.4136 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.